Physician

William Clarence Brink, MD

According to 2025 Medicare claims, William Brink, MD (NPI: 1619933447) practices internal medicine in the Winchester, VA-WV market, with the plurality of this provider's patient population coming from Frederick, VA. This provider's primary affiliated billing organization is WINCHESTER INTERNAL MEDICINE, INC (NPI: 1730130667; TIN: 540952457) and primary practice location at 22601-2872. Brink is affiliated with the ACO West Virginia (ACO ID: A3563), Aledade 94 VA MSSP Enhanced (ACO ID: A4996), Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Brink's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 690 traditional Medicare patients, billed 11,210 HCPCS/CPT codes, and received $359,136 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 14,671 prescription claims across 792 beneficiaries totaling $1,466,243 in drug costs, led by Eliquis (Apixaban). DME data shows 568 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $850,323 to $1,466,243. In contrast, DME billing represents a smaller volume and rose steadily, from $30,629 to $39,702.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,283	13,875	$373,983
2016	1,107	13,780	$394,626
2017	817	12,732	$376,874
2018	798	12,455	$360,796
2019	821	11,374	$333,628
2020	816	10,389	$308,450
2021	783	11,551	$367,039
2022	791	11,197	$365,425
2023	740	11,177	$370,953
2024	690	11,210	$359,136

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	601	12,984	$850,323
2016	626	14,052	$874,054
2017	631	14,446	$982,078
2018	641	14,237	$1,103,807
2019	634	13,562	$1,150,768
2020	696	12,864	$1,169,911
2021	716	12,930	$1,360,380
2022	777	13,303	$1,452,507
2023	754	13,244	$1,516,322
2024	792	14,671	$1,466,243

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	268	820	$28,854
2016	280	759	$19,649
2017	310	762	$14,473
2018	308	852	$20,010
2019	297	846	$20,068
2020	341	851	$24,899
2021	268	785	$28,487
2022	229	695	$30,111
2023	191	631	$32,308
2024	185	568	$35,171

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	551	981	$77
80061	Blood test, lipids (cholesterol and triglycerides)	573	979	$13
80053	Blood test, comprehensive group of blood chemicals	609	1,172	$10
36415	Insertion of needle into vein for collection of blood sample	624	1,490	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	607	1,025	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	382	24,713	$467,103
Januvia	Sitagliptin Phosphate	100	6,814	$117,436
Jardiance	Empagliflozin	80	5,607	$102,220
Ozempic	Semaglutide	72	2,764	$89,476
Xarelto	Rivaroxaban	53	3,461	$62,177

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	38	$16,607
A7030	Full face mask used with positive airway pressure device, each	N	12	33	$2,576
A7031	Face mask interface, replacement for full face mask, each	N	11	27	$2,238
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	54	$2,173
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	18	$1,943

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for William Clarence Brink, MD?

Tedicare shows public-source Medicare data for William Clarence Brink, MD (NPI 1619933447), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William Clarence Brink, MD have ACO affiliation data?

William Clarence Brink, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563), Aledade 94 VA MSSP Enhanced (MSSP, ACO ID A4996), Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to William Clarence Brink, MD?

William Clarence Brink, MD is linked to WINCHESTER INTERNAL MEDICINE, INC (billing NPI 1730130667) in the available physician profile data.

Does William Clarence Brink, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.